Celldex Therapeutics, Inc. (CLDX)
28.25
-1.68
(-5.61%)
USD |
NASDAQ |
Nov 05, 16:00
27.87
-0.38
(-1.35%)
After-Hours: 19:32
Celldex Therapeutics Market Cap : 2.218B for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2026 | 2.350B |
| November 03, 2026 | 2.332B |
| November 02, 2026 | 2.280B |
| October 30, 2026 | 2.363B |
| October 29, 2026 | 2.346B |
| October 28, 2026 | 2.328B |
| October 27, 2026 | 2.367B |
| October 26, 2026 | 2.316B |
| October 23, 2026 | 2.296B |
| October 22, 2026 | 2.274B |
| October 21, 2026 | 2.306B |
| October 20, 2026 | 2.378B |
| October 19, 2026 | 2.329B |
| October 16, 2026 | 2.161B |
| October 15, 2026 | 2.271B |
| October 14, 2026 | 2.185B |
| October 13, 2026 | 2.218B |
| October 12, 2026 | 2.310B |
| October 09, 2026 | 2.346B |
| October 08, 2026 | 2.300B |
| October 07, 2026 | 2.389B |
| October 06, 2026 | 2.434B |
| October 05, 2026 | 2.558B |
| October 02, 2026 | 2.485B |
| October 01, 2026 | 2.526B |
| Date | Value |
|---|---|
| September 30, 2026 | 2.544B |
| September 29, 2026 | 2.484B |
| September 28, 2026 | 2.472B |
| September 25, 2026 | 2.441B |
| September 24, 2026 | 2.471B |
| September 23, 2026 | 2.443B |
| September 22, 2026 | 2.631B |
| September 21, 2026 | 2.974B |
| September 18, 2026 | 3.002B |
| September 17, 2026 | 3.060B |
| September 16, 2026 | 3.039B |
| September 15, 2026 | 3.023B |
| September 14, 2026 | 3.076B |
| September 11, 2026 | 2.897B |
| September 10, 2026 | 2.991B |
| September 09, 2026 | 3.044B |
| September 08, 2026 | 3.071B |
| September 04, 2026 | 3.115B |
| September 03, 2026 | 3.091B |
| September 02, 2026 | 3.099B |
| September 01, 2026 | 3.080B |
| August 31, 2026 | 3.111B |
| August 28, 2026 | 3.071B |
| August 27, 2026 | 3.176B |
| August 26, 2026 | 3.185B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654B |
| Alnylam Pharmaceuticals, Inc. | 20.95B |
| Anika Therapeutics, Inc. | 258.22M |
| Savara, Inc. | 899.65M |
| Vericel Corp. | 2.642B |
Market Cap Related Metrics
| PS Ratio | 12395.80 |
| PEG Ratio | -0.1443 |
| Price to Book Value | 3.103 |
| Price | 28.25 |
| Earnings Yield | -15.43% |
| PEGY Ratio | -0.1443 |